Back to search

Article

Determining the return on investment of a global adaptive platform trial for critically ill patients during COVID-19: A value of implementation analysis in low- and middle-income countries and globally

2026-07-23

Abstract excerpt

<title>Abstract</title> <p> <bold>Introduction:</bold> Adaptive platform trials rapidly generate robust evidence, essential for resource-limited health systems like those in low- and middle-income countries (LMICs). We analyzed the return on investment of an adaptive platform trial using Value of Implementation analysis. <bold>Methods:</bold> This was a retrospective observational cohort study comparing the u...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
15e44d7e-097e-5f60-acdc-4086223b11ab
DOI
10.21203/rs.3.rs-6264788/v3
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Determining the return on investment of a global adaptive platform trial for critically ill patients during COVID-19: A value of implementation analysis in low- and middle-income countries and globallyDOI 10.21203/rs.3.rs-6264788/v3
Select a neighboring publication to make it the new centre.